{"id":"dose-1-of-glycopyrronium-2-5-qd","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Dry mouth"},{"rate":"5-10%","effect":"Blurred vision"},{"rate":"5-10%","effect":"Headache"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"By inhibiting the muscarinic acetylcholine receptors, glycopyrronium decreases the parasympathetic nervous system's effect on the salivary and sweat glands, resulting in reduced secretions.","oneSentence":"Glycopyrronium is an anticholinergic that works by blocking the action of acetylcholine at muscarinic receptors, leading to reduced salivation and sweating.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:11:07.682Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of glaucoma"}]},"trialDetails":[{"nctId":"NCT02129660","phase":"PHASE2","title":"Comparator Study of the Effect of Glycopyrrolate and Glycopyrronium in Subjects With Axillary Hyperhidrosis","status":"COMPLETED","sponsor":"Journey Medical Corporation","startDate":"2014-04","conditions":"Hyperhidrosis","enrollment":105}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["DRM04"],"phase":"phase_2","status":"active","brandName":"Dose 1 of glycopyrronium, 2.5% QD","genericName":"Dose 1 of glycopyrronium, 2.5% QD","companyName":"Journey Medical Corporation","companyId":"journey-medical-corporation","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Glycopyrronium is an anticholinergic that works by blocking the action of acetylcholine at muscarinic receptors, leading to reduced salivation and sweating. Used for Treatment of glaucoma.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}